↓ Skip to main content

Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial.

Overview of attention for article published in JNCI: Journal of the National Cancer Institute, April 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
16 news outlets
twitter
36 X users
facebook
2 Facebook pages
wikipedia
1 Wikipedia page

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
46 Mendeley
Title
Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial.
Published in
JNCI: Journal of the National Cancer Institute, April 2019
DOI 10.1093/jnci/djz068
Pubmed ID
Authors

Angela Mariotto, Jinani Jayasekerea, Valentina Petkov, Clyde B Schechter, Lindsey Enewold, Kathy J Helzlsouer, Eric J Feuer, Jeanne S Mandelblatt

X Demographics

X Demographics

The data shown below were collected from the profiles of 36 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 13%
Other 5 11%
Student > Master 5 11%
Student > Bachelor 3 7%
Professor 3 7%
Other 9 20%
Unknown 15 33%
Readers by discipline Count As %
Medicine and Dentistry 7 15%
Biochemistry, Genetics and Molecular Biology 3 7%
Psychology 3 7%
Engineering 3 7%
Agricultural and Biological Sciences 3 7%
Other 9 20%
Unknown 18 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 135. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2021.
All research outputs
#310,202
of 25,604,262 outputs
Outputs from JNCI: Journal of the National Cancer Institute
#200
of 7,870 outputs
Outputs of similar age
#6,603
of 364,052 outputs
Outputs of similar age from JNCI: Journal of the National Cancer Institute
#2
of 62 outputs
Altmetric has tracked 25,604,262 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,870 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,052 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.